Novo Holdings A/S

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Novo Holdings A/S reported 35 stock positions worth $1.4 billion. Its top holding was ASML Holding NV-NY Reg SHS (ASML) at 12.2% of the portfolio, followed by Brookfield (BN, 11.2%) and Salesforce (CRM, 10.0%). Compared with Q4 2023, it opened 5 new positions, sold out of 6, added to 1 and reduced 8. The biggest buy was a new position in Edgewell Personal Care (EPC) and the biggest sale an exit from Taiwan Semiconductor-SP ADR (TSM).

Most Recent 13F
Q2 2026
Location
HELLERUP, G7
CIK
0001388325
Portfolio Value
$1.4B (Q1 2024)
SEC Filing
0000950123-24-005208 ↗ filed May 15, 2024

Holdings Value

0$500.0M$1.0B$1.5B$2.0B$2.5B Q1 2024: $1.4B $1.4B Q1 2024 Q2 2024: $1.9B Q2 2024 Q3 2024: $2.0B Q3 2024 Q4 2024: $1.7B Q4 2024 Q1 2025: $1.3B Q1 2025 Q2 2025: $1.4B Q2 2025 Q3 2025: $1.6B Q3 2025 Q4 2025: $1.3B Q4 2025 Q1 2026: $1.2B Q1 2026 Q2 2026: $1.7B Q2 2026

Holdings 35 stocks · $1.4B
ASML ASML Holding NV-NY Reg SHS 12.22% 182,536 $177.1M Reduce -7.7%
BN Brookfield Corp. 11.21% 3,880,230 $162.5M No change
CRM Salesforce Inc. 9.98% 480,160 $144.6M Reduce -9.5%
EPC Edgewell Personal Care Co. 7.98% 6,344,430 $115.7M New
CORT Corcept Therapeutics Inc. 4.19% 2,411,362 $60.7M No change
PCVX Vaxcyte Inc. 3.98% 845,000 $57.7M No change
CRNX Crinetics Pharmaceuticals Inc. 3.55% 1,098,600 $51.4M Reduce -0.1%
CABO Cable One Inc. 3.46% 118,403 $50.1M No change
LANZATECH GLOBAL INC 3.38% 15,814,845 $48.9M No change
FDMT 4D Molecular Therapeutics Inc. 3.08% 1,400,000 $44.6M Reduce -6.7%
BMRN Biomarin Pharmaceutical Inc. 2.71% 450,000 $39.3M No change
MIRM Mirum Pharmaceuticals Inc. 2.60% 1,500,000 $37.7M No change
INSM Insmed Inc. 2.51% 1,339,304 $36.3M No change
BABA Alibaba Group Holding-SP ADR 2.50% 500,827 $36.2M No change
BPMC Blueprint Medicines Corp. 2.35% 358,626 $34.0M Reduce -0.1%
AAPL Apple Inc. 2.16% 182,960 $31.4M Reduce -17.4%
FOLD Amicus Therapeutics Inc. 2.03% 2,500,000 $29.4M No change
RCKT Rocket Pharmaceuticals Inc. 1.95% 1,050,000 $28.3M No change
CRGX Cargo Therapeutics Inc. 1.92% 1,250,000 $27.9M No change
PHVS Pharvaris NV 1.86% 1,168,030 $27.0M Reduce -24.1%
VERV Verve Therapeutics Inc. 1.83% 2,000,000 $26.6M No change
BAM Brookfield Asset Mgmt-A 1.82% 627,207 $26.4M No change
LXEO Lexeo Therapeutics Inc. 1.77% 1,638,298 $25.7M Add +25.3%
VRDN Viridian Therapeutics Inc. 1.33% 1,100,000 $19.3M New
AVBP Arrivent Biopharma Inc. 1.33% 1,077,140 $19.2M New
MGX Metagenomi Therapeutics Inc. 1.27% 1,739,175 $18.3M New
ALNY Alnylam Pharmaceuticals Inc. 1.22% 118,383 $17.7M No change
KYTX Kyverna Therapeutics Inc. 1.20% 700,000 $17.4M New
INSP Inspire Medical Systems Inc. 0.97% 65,524 $14.1M No change
IOBTQ Io Biotech Inc. 0.61% 5,088,258 $8.8M Reduce -11.5%
ABCL Abcellera Biologics Inc. 0.35% 1,126,915 $5.1M No change
TMCI Treace Medical Concepts Inc. 0.32% 360,000 $4.7M No change
MQ Marqeta Inc. 0.18% 441,558 $2.6M No change
GALECTO INC 0.13% 2,497,791 $1.9M No change
SPRO Spero Therapeutics Inc. 0.06% 468,902 $807K No change

Portfolio Sells Q4 2023 → Q1 2024
TSM Taiwan Semiconductor-SP ADR Sold out 0.00% −4.56
EWTX Edgewise Therapeutics Inc. Sold out 0.00% −4.10
CBAY Cymabay Therapeutics Inc. Sold out 0.00% −1.31
SPRB Spruce Biosciences Inc. Sold out 0.00% −1.22
PHVS Pharvaris NV Reduce -24.1% 1.86% −0.80
AAPL Apple Inc. Reduce -17.4% 2.16% −0.47
RLYB Rallybio Corp. Sold out 0.00% −0.26
LVTX Lava Therapeutics NV Sold out 0.00% −0.18
IOBTQ Io Biotech Inc. Reduce -11.5% 0.61% −0.06
BPMC Blueprint Medicines Corp. Reduce -0.1% 2.35% +0.30
CRNX Crinetics Pharmaceuticals Inc. Reduce -0.1% 3.55% +1.13
FDMT 4D Molecular Therapeutics Inc. Reduce -6.7% 3.08% +1.20
CRM Salesforce Inc. Reduce -9.5% 9.98% +1.36
ASML ASML Holding NV-NY Reg SHS Reduce -7.7% 12.22% +2.98

Portfolio Buys Q4 2023 → Q1 2024
EPC Edgewell Personal Care Co. New 7.98% +7.98
VRDN Viridian Therapeutics Inc. New 1.33% +1.33
AVBP Arrivent Biopharma Inc. New 1.33% +1.33
MGX Metagenomi Therapeutics Inc. New 1.27% +1.27
KYTX Kyverna Therapeutics Inc. New 1.20% +1.20
LXEO Lexeo Therapeutics Inc. Add +25.3% 1.77% +0.69

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 25$1.7BEWTX, ASML, COAG, BN, MPLT
Q1 2026 22$1.2BEWTX, BN, ASML, MIRM, MPLT
Q4 2025 24$1.3BBN, EWTX, ASML, MIRM, CRM
Q3 2025 27$1.6BVTI, BN, ASML, MIRM, EWTX
Q2 2025 29$1.4BVTI, BN, ASML, CRM, MIRM
Q1 2025 31$1.3BVTI, BN, EWTX, ASML, CRM
Q4 2024 34$1.7BVTI, BN, TEM, EWTX, ASML
Q3 2024 37$2.0BVTI, TEM, BN, EWTX, CORT
Q2 2024Amended 38$1.9BVTI, BN, TEM, ASML, CRM
Q1 2024 35$1.4BASML, BN, CRM, EPC, CORT